Interleukin-17
Showing 1 - 25 of 6,448
Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
Not yet recruiting
- JIA
- serum levels of interleukin-17A in JIA
- (no location specified)
Jan 15, 2023
Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)
Completed
- Psoriasis Vulgaris
- UVB Phototherapy Burn
- Serum Interleukin 17 levels
- NB-UVB
-
Qinā, Qena, EgyptSouth Valley University
Dec 9, 2022
Psoriasis Vulgaris Trial in Surabaya (Lactobacillus Plantarum IS-10506, Placebo)
Recruiting
- Psoriasis Vulgaris
- Lactobacillus Plantarum IS-10506
- Placebo
-
Surabaya, Jawa Timur, IndonesiaUniversitas Airlangga
Feb 15, 2022
MDD Trial in New York (Ixekizumab, Placebo)
Recruiting
- Major Depressive Disorder
- Ixekizumab
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 16, 2021
Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)
Active, not recruiting
- Uveitis
-
Los Angeles, California
- +3 more
Jul 18, 2022
Idiopathic Subglottic Stenosis Trial in New Haven (Taltz)
Not yet recruiting
- Idiopathic Subglottic Stenosis
-
New Haven, ConnecticutYale New Haven Hospital
Jul 21, 2022
Mouth Diseases, Periodontal Inflammation, Periodontal Diseases Trial in Antalya (GCF obtaining, Saliva Obtaining, Serum
Completed
- Mouth Diseases
- +2 more
- GCF obtaining
- +2 more
-
Antalya, TurkeyAkdeniz University Faculty of Dentistry
Jun 29, 2022
Plaque Psoriasis, Non-alcoholic Fatty Liver Disease Trial in Germany, Spain (Investigational Arm - secukinumab, Control Arm - )
Completed
- Plaque Psoriasis
- Non-alcoholic Fatty Liver Disease
- Investigational Arm - secukinumab
- Control Arm - placebo
-
Erlangen, Germany
- +7 more
Jan 12, 2022
Psoriasis Trial in Saint Petersburg (BCD-085, Placebo)
Completed
- Psoriasis
- BCD-085
- Placebo
-
Saint Petersburg, Strelna, Russian FederationBIOCAD
Feb 26, 2021
Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)
Completed
- Covid19
- Ixekizumab
- +3 more
-
Ribeirão Preto, SP, Brazil
- +1 more
Jul 26, 2022
Th17 Helper Immune Cells, Autoimmunity, Salt Intake Trial in Boston (Low salt diet, Low salt diet + IV normal saline, Liberal
Terminated
- Th17 Helper Immune Cells
- +3 more
- Low salt diet
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 4, 2021
Aggressive Periodontitis Trial (Klorhex® Gel, rinse and spray, Conventional IPT, Full-mouth IPT)
Completed
- Aggressive Periodontitis
- Klorhex® Gel, rinse and spray
- +2 more
- (no location specified)
May 27, 2020
Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)
Recruiting
- Subarachnoid Hemorrhage
- IL-1Ra
- IL-1Ra Placebo
-
Plymouth, Devon, United Kingdom
- +11 more
May 16, 2022
Non-Alcoholic Fatty Liver Disease, Probiotics MeSH Descriptor Data 2018, Interleukin-17 MeSH Descriptor Data 2018 Trial in
Terminated
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Probiotic Formulation VSL#3
-
Manhasset, New YorkNorthwell Health
Jan 3, 2020
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023
Plaque Psoriasis Trial in Karachi (Secukinumab Injection)
Completed
- Plaque Psoriasis
- Secukinumab Injection
-
Karachi, Sindh, PakistanJinnah Post graduate Medical centre
Jun 4, 2023
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Inflammatory and Anti-Inflammatory Gene Expressions in Liver
Active, not recruiting
- Liver Transplant; Complications
- +3 more
- Molecular Immunology , gene expressions
-
Malatya, Turkeyİnönü University
May 2, 2023
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Vaccine Adverse Reaction, Side-Effect Trial (Mulberry juice)
Not yet recruiting
- Vaccine Adverse Reaction
- Side-Effect
- Mulberry juice
- (no location specified)
May 20, 2022